AzTrials
AzTrials

Insomnia ChronicNiteCAPPNCT04632628

Web-based Cognitive Behavioral Treatment for Insomnia in Dementia Caregivers

A study testing Web-based Cognitive Behavior Therapy for Insomnia (CBT-I) in people with Insomnia Chronic and Dementia, run by University of South Florida at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Over the next 30 years, more than 10 million persons living with dementia in the United States will receive care at home from an unpaid and untrained family caregiver. At home care is preferred by caregivers and persons with dementia alike, but increases the caregiver's risk of insomnia and related negative health… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Insomnia Chronic, Dementia
What is being tested?
Web-based Cognitive Behavior Therapy for Insomnia (CBT-I)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
14 Nov 2023to 30 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18+ yrs
  • Dementia caregiver living with person with dementia
  • willing to be randomized, 4. read/understand English
  • insomnia diagnosis
  • no prescribed or over-the-counter sleep meds or stabilized 6+ weeks.
  • Insomnia:
Show all 16Show fewer
  • complaints for 6+ mos
  • adequate opportunity and circumstances for sleep
  • 1+ of the following: difficulty falling asleep, staying asleep, or waking too early
  • daytime dysfunction (mood, cognitive, social, occupational) due to insomnia
  • Screening interview indicates Insomnia Severity Index score ≥11 or Insomnia Severity Index score 9-10
  • baseline diaries indicate >30 mins of sleep onset latency or wake after sleep onset on 3+ nts.
  • 18+ yrs
  • Persons with dementia living with caregiver
  • Have an eligible caregiver
  • willing to be randomized

Who cannot join

  • unable to consent
  • cognitive impairment [Telephone Interview for Cognitive Status (TICS) <25 or Mini Mental State Examination (MMSE) <26]
  • sleep disorder other than insomnia [i.e., sleep apnea (apnea/hypopnea index, AHI >15)]
  • bipolar or seizure disorder
  • other major psychopathology except depression or anxiety (e.g., suicidal ideation/intent, psychosis)
  • severe untreated psychiatric comorbidity
Show all 10Show fewer
  • psychotropic or other medications (e.g., beta-blockers) that alter sleep
  • non-pharmacological tx for sleep or mood outside current trial.
  • PERSONS WITH DEMENTIA
  • Person with dementia or legally authorized representative is unable to consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • University of Missouri

    Columbia, Missouri, 65212

    Christina McCrae

    Riley Stephens

    Recruiting

Other trials in United States

About this study

Over the next 30 years, more than 10 million persons living with dementia in the United States will receive care at home from an unpaid and untrained family caregiver. At home care is preferred by caregivers and persons with dementia alike, but increases the caregiver's risk of insomnia and related negative health outcomes, including depression, anxiety, cognitive disturbances and poor quality of life. Cognitive behavioral therapy for insomnia (CBT-I) is a highly effective and established evidence based treatment for adults of all ages. Although relatively understudied in dementia caregivers, the research by our group and others suggests CBT-I is also efficacious in caregivers. Our team developed a brief (4 session) CBT-I protocol specifically adapted for dementia caregivers (CBT-I) and has shown in person and remote (i.e. telehealth) delivery of this protocol significantly reduces insomnia symptoms and improves mood (moderate to large effects). Given demands on caregivers' time and limited availability of trained CBT-I providers, a web-based version of CBT-I (WebCBT-I; the online treatment will be called NiteCAPP) is needed to increase the accessibility of this efficacious treatment. WebCBT-I will allow for flexible at home scheduling, and the skills needed to monitor caregiver treatment progress can be quickly and efficiently taught to healthcare providers. The overarching goal of this project is to develop and test WebCBT-I in caregivers of persons with dementia.

Objectives

  1. To examine the clinical and health characteristics, including sleep, pain, fatigue, cognitive abilities, and cardiovascular health in dementia caregivers with insomnia.
  2. To examine changes in the primary clinical outcomes, including complaints of poor sleep, and fatigue.
  3. To examine changes in the secondary clinical outcomes, including mood, daytime functioning, cognitive functioning, and cardiovascular health.
  4. To examine the mechanistic variables, including arousal (heart rate variability, HRV).
Being tested
Web-based Cognitive Behavior Therapy for Insomnia (CBT-I)
Keywords
Dementia Caregiver, Sleep, Behavioral Interventions, Online Behavioral Intervention, Insomnia, Dementia
Medical subject headings
Sleep Initiation and Maintenance Disorders, Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Web-based Cognitive Behavior Therapy for Insomnia (CBT-I)Behavioural

    Participants will complete 4 web-based CBT- I sessions. Lesson 1: Sleep Hygiene and Stimulus Control Lesson 2: Sleep Restriction and Relaxation Strategies Lesson 3: Identifying and Restructuring Dysfunction Thoughts Lesson 4: Practical Recommendations, Review, and Maintenance of Change

Study groups in NCT04632628
Study groupRoleWhat they receive
NiteCAPP: Online Cognitive Behavioral Therapy for InsomniaExperimentalThis is a pilot trial with one treatment condition (CBT-I).
Receives: Behavioral: Web-based Cognitive Behavior Therapy for Insomnia (CBT-I)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Daily Electronic Sleep and Pain Diaries - Sleep Onset Latency

    Subjective sleep onset latency (time to fall asleep)

    Measured: 6 weeks

  2. Daily Electronic Sleep and Pain Diaries - Wake-time After Sleep Onset

    Subjective time awake after sleep onset

    Measured: 6 weeks

  3. Daily Electronic Sleep and Pain Diaries - Total Sleep Time

    Subjective total sleep time

    Measured: 6 weeks

  4. Daily Electronic Sleep and Pain Diaries - Sleep Efficiency

    Subjective sleep efficiency

    Measured: 6 weeks

  5. Daily Electronic Sleep and Pain Diaries - Pain Intensity & Unpleasantness

    Pain Intensity \& Unpleasantness

    Measured: 6 weeks

  6. Daily Electronic Sleep and Pain Diaries - Medication Consumption

    Sleep and pain medication consumption

    Measured: 6 weeks

  7. Objective Daily Sleep Actiwatch-2 - Sleep Onset Latency

    Objective sleep onset latency (time to fall asleep)

    Measured: 6 weeks

  8. Objective Daily Sleep Actiwatch-2 - Wake-time After Sleep Onset

    Objective time awake after sleep onset

    Measured: 6 weeks

  9. Objective Daily Sleep Actiwatch-2 - Total Sleep Time

    Objective total sleep time

    Measured: 6 weeks

  10. Objective Daily Sleep Actiwatch-2 - Sleep Efficiency

    Objective sleep efficiency

    Measured: 6 weeks

  11. Insomnia Severity Index

    Insomnia severity measurement; min: 0 max:28; higher score means greater insomnia severity

    Measured: 6 weeks

Secondary outcomes (12)
  1. State Trait Anxiety Inventory (STAI-Y1)

    Assessment of anxiety symptoms - min: 0 max:60; higher score means higher anxiety

    Measured: 6 weeks

  2. Beck Depression Inventory Second Edition (BDI- II)

    Depressive symptom assessment - min: 0 max: 63; Higher score means higher severity of depression

    Measured: 6 weeks

  3. Perceived Stress Scale (PSS)

    Perception of stress - min: 0; max:40 - higher scores indicate higher perceived stress

    Measured: 6 weeks

  4. Kingston Caregiver Stress Scale

    Caregiver stress measurement - min:10 max:50 - higher score indicates higher caregiver stress

    Measured: 6 weeks

  5. Dysfunctional Attitudes/Beliefs about Sleep (DBAS)

    evaluates sleep-related beliefs, expectations and attitudes regarding the causes, consequences, and potential treatments of sleep issues - higher scores indicates more dysfunctional beliefs and attitudes

    Measured: 6 weeks

  6. Caregiver Functional Unit Scale

    Assessment of the stability of the patient-caregiver dyad - higher score indicates lower stability

    Measured: 6 weeks

  7. Online Cognitive Assessment - Stroop

    Determine level of cognitive functioning

    Measured: 6 weeks

  8. Online Cognitive Assessment - Sternberg

    Determine level of cognitive functioning

    Measured: 6 weeks

  9. Online Cognitive Assessment - Wisconsin Card Sorting Task

    Determine level of cognitive functioning

    Measured: 6 weeks

  10. Cognitive Failures Questionnaire

    Self-reported failures in perception, memory, and motor function - min:0 max: 100 - higher score indicates greater cognitive failure

    Measured: 6 weeks

  11. Dementia Patient's Caregiver Quality of Life Scale

    Assessment of caregiver quality of life - min: 0 max:100 - higher score indicates good quality of life

    Measured: 6 weeks

  12. Zarit Burden Scale

    Caregiver burden measurement - min: 0 max: 48 - higher score indicated higher caregiver burden

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Nov 2020
  2. Study start14 Nov 2023
  3. Primary completion30 Sep 2027 (estimated)
  4. Study completion30 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04632628
Sponsor's protocol ID
2017125
Acronym
NiteCAPP
Status last verified
Jun 2026
First submitted
10 Nov 2020
Last updated
15 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Rowe MA, McCrae CS, Campbell JM, Benito AP, Cheng J. Sleep pattern differences between older adult dementia caregivers and older adult noncaregivers using objective and subjective measures. J Clin Sleep Med. 2008 Aug 15;4(4):362-9.

    PubMed 18763429
  • Fonareva I, Amen AM, Zajdel DP, Ellingson RM, Oken BS. Assessing sleep architecture in dementia caregivers at home using an ambulatory polysomnographic system. J Geriatr Psychiatry Neurol. 2011 Mar;24(1):50-9. doi: 10.1177/0891988710397548.

    PubMed 21320949
  • Beaudreau SA, Spira AP, Gray HL, Depp CA, Long J, Rothkopf M, Gallagher-Thompson D. The relationship between objectively measured sleep disturbance and dementia family caregiver distress and burden. J Geriatr Psychiatry Neurol. 2008 Sep;21(3):159-65. doi: 10.1177/0891988708316857. Epub 2008 May 23.

    PubMed 18503035
  • Creese J, Bedard M, Brazil K, Chambers L. Sleep disturbances in spousal caregivers of individuals with Alzheimer's disease. Int Psychogeriatr. 2008 Feb;20(1):149-61. doi: 10.1017/S1041610207005339. Epub 2007 Apr 30.

    PubMed 17466086
  • McCurry SM, Logsdon RG, Teri L, Vitiello MV. Sleep disturbances in caregivers of persons with dementia: contributing factors and treatment implications. Sleep Med Rev. 2007 Apr;11(2):143-53. doi: 10.1016/j.smrv.2006.09.002. Epub 2007 Feb 6.

    PubMed 17287134
  • McCrae CS, Wilson NM, Lichstein KL, Durrence HH, Taylor DJ, Bush AJ, Riedel BW. 'Young old' and 'old old' poor sleepers with and without insomnia complaints. J Psychosom Res. 2003 Jan;54(1):11-9. doi: 10.1016/s0022-3999(02)00543-3.

    PubMed 12505551
  • Mahoney DF. Vigilance. Evolution and definition for caregivers of family members with Alzheimer's disease. J Gerontol Nurs. 2003 Aug;29(8):24-30. doi: 10.3928/0098-9134-20030801-07.

    PubMed 13677157
  • McCrae CS, Curtis AF, Williams JM, Dautovich ND, McNamara JPH, Stripling A, Dzierzewski JM, Chan WS, Berry RB, McCoy KJM, Marsiske M. Efficacy of brief behavioral treatment for insomnia in older adults: examination of sleep, mood, and cognitive outcomes. Sleep Med. 2018 Nov;51:153-166. doi: 10.1016/j.sleep.2018.05.018. Epub 2018 Jun 2.

    PubMed 30195661
  • Edinger JD, Wohlgemuth WK, Krystal AD, Rice JR. Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med. 2005 Nov 28;165(21):2527-35. doi: 10.1001/archinte.165.21.2527.

    PubMed 16314551
  • McCrae CS, McGovern R, Lukefahr R, Stripling AM. Research Evaluating Brief Behavioral Sleep Treatments for Rural Elderly (RESTORE): a preliminary examination of effectiveness. Am J Geriatr Psychiatry. 2007 Nov;15(11):979-82. doi: 10.1097/JGP.0b013e31813547e6.

    PubMed 17974868
  • Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005 Nov 19;331(7526):1169. doi: 10.1136/bmj.38623.768588.47. Epub 2005 Nov 11.

    PubMed 16284208
  • Allain H, Bentue-Ferrer D, Polard E, Akwa Y, Patat A. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging. 2005;22(9):749-65. doi: 10.2165/00002512-200522090-00004.

    PubMed 16156679
  • Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Ann Intern Med. 2015 Aug 4;163(3):191-204. doi: 10.7326/M14-2841.

    PubMed 26054060
  • Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia: NHANES 1999-2010. Sleep. 2014 Feb 1;37(2):343-9. doi: 10.5665/sleep.3410.

    PubMed 24497662
  • Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016 Jul 19;165(2):125-33. doi: 10.7326/M15-2175. Epub 2016 May 3.

    PubMed 27136449

Questions about this trial

What is this clinical trial studying?

A study testing Web-based Cognitive Behavior Therapy for Insomnia (CBT-I) in people with Insomnia Chronic and Dementia, run by University of South Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christina S McCrae (573-882-0982, mccraec@health.missouri.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Daily Electronic Sleep and Pain Diaries - Sleep Onset Latency (time frame: 6 weeks). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04632628, which also lists 47 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in